# SOFTLOGIC HOLDINGS PLC Financial Summary

Canonical URL: https://pal.lk/updates/shl-financial-summary
Symbol: SHL.N0000
Company: SOFTLOGIC HOLDINGS PLC
Sector: Financial Services
Published: 2026-09-18T05:15:43Z
Last updated: 2026-09-18T05:15:43Z

# Softlogic Holdings PLC Financial Summary and Investment Analysis

## Executive Overview
Softlogic Holdings PLC is a leading diversified conglomerate in Sri Lanka with significant operations across Retail & Telecommunications, Healthcare Services (Asiri Health), Financial Services, Information Technology, Leisure & Property, and Automobiles. The company is currently navigating a pivotal turnaround phase, recovering from macroeconomic shocks (import bans, hyperinflation, and high-interest rates). 

Recent periods indicate a strong operational rebound, evidenced by robust top-line growth, improved operating leverage, and positive EBITDA. However, the Group faces a "Material Uncertainty Related to Going Concern" due to substantial accumulated losses, a significant net liability position, and heavy debt burdens. Management is aggressively executing a liquidity and working capital enhancement plan, which includes restructuring bank facilities, equity infusions via rights issues and warrants, and strategic asset monetization (e.g., re-purposing the ODEL Mall project). 
- **Key periods covered**: CY2023 Q1 (Year ended 31 March 2023) to CY2026 Q2 (Three months ended 30 June 2026).

## Financial Performance

### Revenue and Profitability Trends
The Group's top line has demonstrated a solid recovery trajectory, primarily driven by the relaxation of import bans (benefiting Retail, Telecommunications, and Automobiles) and steady growth in Healthcare and Financial Services. Operating leverage has improved, leading to a substantial 43% EBITDA growth in the 12 months ending CY2026 Q1 compared to the prior year. Despite these improvements, high finance costs continue to weigh down the bottom line, though net losses have significantly narrowed (a 67% reduction in net losses YoY in CY2026 Q1).

| Period (End Date) | Duration | Revenue (Rs. '000) | Gross Profit (Rs. '000) | Net Profit/Loss (Rs. '000) | GP Margin | NP Margin |
|-------------------|----------|--------------------|-------------------------|----------------------------|-----------|-----------|
| CY2026 Q2 (30-Jun-2026) | 3 Months | 34,073,784 | 13,118,285 | (1,822,121) | 38.50% | -5.35% |
| CY2026 Q1 (31-Mar-2026) | 12 Months | 128,995,343 | 45,997,884 | (3,592,315) | 35.66% | -2.78% |
| CY2025 Q4 (31-Dec-2025) | 9 Months | 93,746,184 | 32,900,320 | (2,887,307) | 35.10% | -3.08% |
| CY2025 Q3 (30-Sep-2025) | 6 Months | 60,270,541 | 20,705,436 | (3,159,116) | 34.35% | -5.24% |
| CY2025 Q2 (30-Jun-2025) | 3 Months | 30,041,482 | 10,214,685 | (1,673,022) | 34.00% | -5.57% |
| CY2025 Q1 (31-Mar-2025) | 12 Months | 103,622,145 | 37,691,739 | (11,085,178) | 36.37% | -10.70% |
| CY2024 Q4 (31-Dec-2024) | 9 Months | 75,882,548 | 27,502,525 | (7,693,554) | 36.24% | -10.14% |
| CY2024 Q3 (30-Sep-2024) | 6 Months | 48,232,556 | 16,410,620 | (6,079,872) | 34.02% | -12.61% |
| CY2024 Q2 (30-Jun-2024) | 3 Months | 24,125,919 | 8,143,958 | (2,621,504) | 33.76% | -10.87% |
| CY2024 Q1 (31-Mar-2024) | 12 Months | 99,839,171 | 33,049,659 | (15,200,188) | 33.10% | -15.22% |

**Analysis**: 
- **YoY Growth**: Revenue for the 12 months ending CY2026 Q1 surged by 24.5% compared to CY2025 Q1, propelled by normalization of the operating environment.
- **Cost Controls**: A decline in administrative distribution expense margins reflects effective cost-containment measures.
- **Finance Costs**: While net finance costs dropped by 16% YoY (from Rs. 6.9 Bn to Rs. 5.8 Bn in CY2026 Q1) due to a lower interest rate environment, the sheer volume of debt ensures finance expenses remain the primary drag on profitability.

### Balance Sheet Analysis
The Group's balance sheet is heavily stressed, marked by negative equity and current liabilities significantly exceeding current assets. Management is addressing this via debt restructuring and capital injections.

| As At Period End | Total Assets (Rs. '000) | Total Liabilities (Rs. '000) | Total Equity (Rs. '000) | Net Debt (Rs. '000) |
|------------------|-------------------------|------------------------------|-------------------------|---------------------|
| CY2026 Q2 (30-Jun-2026) | 209,573,072 | 257,197,788 | (47,624,716) | N/A |
| CY2026 Q1 (31-Mar-2026) | 205,427,103 | 248,355,586 | (42,928,483) | 125,662,700 |
| CY2025 Q4 (31-Dec-2025) | 196,463,458 | 240,261,042 | (43,797,584) | N/A |
| CY2025 Q3 (30-Sep-2025) | 184,940,267 | 205,640,115 | (20,699,848) | N/A |
| CY2025 Q1 (31-Mar-2025) | 178,938,163 | 219,645,111 | (40,706,948) | 125,698,490 |
| CY2024 Q1 (31-Mar-2024) | 179,198,430 | 209,398,361 | (30,199,931) | N/A |

**Analysis**:
- **Solvency**: As of CY2026 Q1, the Group's accumulated losses stood at Rs. 92.5 Bn, leading to a negative Total Equity of Rs. 42.9 Bn. 
- **Liquidity**: The current ratio improved slightly to 0.48x in CY2026 Q1 (from 0.40x in CY2025 Q1) but remains at critical levels. Current liabilities exceeded current assets by Rs. 67.8 Bn.
- **Mitigation**: The Group has secured restructuring arrangements for Rs. 47.5 Bn in debt (extending tenors and securing grace periods) and is pursuing further restructuring of Rs. 15.6 Bn.

### Cash Flow Analysis
Cash generation has materially improved alongside the operational recovery, demonstrating the underlying cash-generating capacity of the businesses before debt service.

| Period (End Date) | Duration | Net Operating CF (Rs. '000) | Net Investing CF (Rs. '000) | Net Financing CF (Rs. '000) |
|-------------------|----------|-----------------------------|-----------------------------|-----------------------------|
| CY2026 Q2 (30-Jun-2026) | 3 Months | 3,622,428 | (4,991,234) | 1,009,006 |
| CY2026 Q1 (31-Mar-2026) | 12 Months | 14,045,755 | 3,402,882 | (2,343,917) |
| CY2025 Q4 (31-Dec-2025) | 9 Months | 13,395,554 | 3,523,923 | (2,241,604) |
| CY2025 Q3 (30-Sep-2025) | 6 Months | 6,244,778 | (7,719,720) | (5,311,959) |
| CY2025 Q1 (31-Mar-2025) | 12 Months | 8,799,782 | 1,617,782 | (8,552,554) |

**Analysis**:
- **Operating Cash Flow**: Jumped by 60% YoY to Rs. 14.0 Bn in CY2026 Q1, reflecting stronger operational performance and improved working capital discipline.
- **Investing & Financing**: Positive investing cash flows in CY2026 Q1 stem from strategic asset monetizations. Financing cash outflows were notably reduced as the Group restructured its debt obligations.

### Key Financial Ratios and Growth Indicators
| Metric | CY2026 Q1 (12M) | CY2025 Q1 (12M) | CY2024 Q1 (12M) |
|--------|-----------------|-----------------|-----------------|
| EBITDA (Rs. '000) | 17,842,000 | 12,468,000 | 9,959,000 |
| Asset Turnover (times) | 0.67 | 0.58 | 0.55 |
| Current Ratio (times) | 0.48 | 0.40 | 0.36 |
| EPS (Rs.) | (6.18) | (11.19) | (15.60) |
| Net Asset Value Per Share (Rs.) | (47.61) | (42.66) | (40.46) |

**Other Indicators**:
- **Workforce**: Maintained a stable headcount of 11,044 employees.
- **New Franchises**: Introduced Mad Over Donuts, Wow! Momo, and Tiong Bahru Bakery to expand the dining portfolio.

## Economic and Market Context
The Group benefited from Sri Lanka's macroeconomic stabilization:
- **GDP Growth & Inflation**: GDP expanded by 5% in CY2025, while inflation transitioned from hyper-inflationary levels to a contained environment, boosting consumer purchasing power.
- **Import Restrictions Lifted**: The resumption of motor vehicle and electronic imports significantly revived the Automobile and Retail & Telecommunications sectors.
- **Tourism Rebound**: Strong tourism arrivals (reaching record levels before slight geopolitical disruptions) supported the Leisure sector.

## Future Potential and Outlook
- **Healthcare Expansion**: A 99-year lease agreement was signed for a 500-bed state-of-the-art hospital in Colombo's Port City in partnership with Mayo Clinic, targeting regional medical tourism. Asiri Group also placed bids to acquire Lanka Hospitals Corporation PLC.
- **Financial Services**: Softlogic Life acquired 100% of Allianz Life Insurance Lanka Ltd and secured a 60% stake in Diamond Life Insurance in Bangladesh, initiating its regional expansion. Softlogic Finance regained regulatory compliance, allowing it to resume deposit mobilization.
- **Leisure**: Rebranded two major properties (Colombo and Bentota) under Accor’s premium "Pullman" brand to leverage global distribution networks.
- **Property/Retail**: The massive ODEL Mall project was strategically recalibrated. The residential component was replaced with office space to facilitate pre-sales funding (targeting Rs. 6.1 Bn), eliminating the need for further debt.

## Risks and Challenges
- **Going Concern & Solvency Risk**: The primary threat is the massive debt overhang and negative equity. The auditors have raised a "Material Uncertainty Related to Going Concern".
- **Refinancing & Interest Rate Risk**: The Group is highly sensitive to interest rate fluctuations given its Rs. 115.8 Bn net interest-bearing borrowing book.
- **Execution Risk on ODEL Mall**: Still exposed to cost escalations and market demand for office space.
- **Mitigation Strategies**: Extensive debt restructuring with banks (Rs. 47.5 Bn already restructured with 6 to 18-month capital grace periods); capital infusion via rights issues (Rs. 2.0 Bn raised) and incoming warrant conversions; strict working capital discipline; and non-core asset sales.

## Shareholder and Corporate Information
- **Major Shareholders**: Mr. A. K. Pathirage (Chairman/MD) holds 44.18%, followed by Samena Ceylon Holdings Ltd with 23.40%.
- **Public Holding**: 11.22% (10,537 public shareholders as of CY2026 Q1).
- **Stock Performance**: Over the last 90 trading sessions (up to Sept 2026), the stock experienced a severe drop, with a 90-session price return of -51.20%, closing at LKR 8.10 (down from LKR 16.60), reflecting market concerns over the equity deficit.
- **Corporate Action**: Trading suspension by the CSE has been deferred until 30 June 2027 to allow the Group to execute its capital restoration plan.

## Investment Decision Indicators

**Strengths & Opportunities**:
- **Strong Top-line Recovery**: 24.5% YoY revenue growth with significant improvements in EBITDA (+43% YoY).
- **Market Leadership**: Dominant, entrenched positions in Healthcare (Asiri), Life Insurance (Softlogic Life - 19.3% market share), and Retail/Electronics.
- **Strategic Pivots**: Transitioning ODEL Mall to a pre-sales funded office model removes a major debt-funding overhang. Expanding into Bangladesh offers fresh demographic opportunities for Life Insurance.
- **Improving Cash Flows**: Operating cash flows surged 60% YoY, proving the underlying businesses are highly viable once isolated from legacy holding-company debt.

**Weaknesses & Threats**:
- **Severe Balance Sheet Distress**: Net liabilities of Rs. 42.9 Bn and an accumulated loss of Rs. 92.5 Bn.
- **Dilution Risk**: Retail investors face massive dilution from ongoing/future rights issues and warrant exercises required to recapitalize the firm.
- **Macro Sensitivity**: Discretionary retail and vehicle sales remain highly sensitive to local tax policies (VAT) and disposable income levels.

**Overall Assessment**:
Softlogic Holdings PLC presents a **high-risk, high-reward restructuring play**. The underlying operating assets (Healthcare, Insurance, Retail) are performing exceptionally well and generating strong operating cash flows. However, the Group is effectively functioning as a distressed asset at the holding level due to massive legacy debt. An investment decision hinges entirely on the investor's confidence in management's ability to successfully execute the remaining debt restructuring, complete the ODEL Mall via pre-sales, and finalize the warrant conversions without wiping out minority shareholder value. It is suited only for investors with a high tolerance for binary outcomes (recovery vs. insolvency).